Good MorningThe equities market ended a strong week on an up note despite growing concerns about the COVID-19 pandemic. The number of new cases continues to set new records even as the broad market S&P 500 tries to set a new all-time closing high. The risk for markets is another shutdown. Although, President-Elect Joe Biden’s advisors backed off the suggestion to close the economy for 6 weeks the threat remains.
Next week could be challenging for the market. It is the mid-month data dump and includes eight major economic reports. Among them are Retail Sales, Business Inventories, The Index of Leading Indicators, and a host of housing data. Strong or stronger than expected figures could send the equity market to new all-time highs despite the threat of COVID and there is every reason to think they will be.
Featured: Free Options Trading eBook: The Ultimate Income System (Base Camp Trading) 
|
Markets | | | Albert Marombe takes a grimy, tattered $1 note and delicately, expertly glues it back into one piece, holding it up for inspection.
“I don’t care how torn it is. All I want to see is the serial number being visible on both sides,” said Marombe. He'll sell that shabby $1 note for 80 ce... Read the Full Story |
|
From Our PartnersWSJ reports that Airbnb plans a secret +$18 billion IPO. That means the Silicon Valley giant is keeping details 100% confidential.
My research analysts dug through public records, interviews, and private sources to prepare this special report: Inside Airbnb's Confidential IPO.
| | Just click here to download your FREE report |
|
Politics | | | Asian shares have mostly fallen as rising cases of coronavirus infections in the U.S., Europe and Asia add to worries that economies will once again be hamstrung by pandemic restrictions on travel and businesses Read the Full Story |
|
Politics | | | Global shares are mostly lower as rising cases of coronavirus infections in the U.S., Europe and Asia add to worries that economies will once again be hamstrung by pandemic restrictions on travel and businesses Read the Full Story |
|
From Our PartnersIt's NOT bitcoin. It's NOT 5G. It's NOT cannabis. But it could be bigger than all of those. This tech is fresh out of a secretive lab in Boston, and early investors are funneling as much money as they can into it. You could be looking down the barrel of 5,000% profits or MORE. | | Free alert explains. |
|
Markets | | |
When we consider which stocks have benefitted from market trends caused by the pandemic, usually the first ones that come to mind are cloud-based software companies, e-commerce companies, and any of the “stay-at-home” stocks. On the other hand, the brick-and-mortar retail industry has ... Read the Full Story |
|
Politics | | | Before fleeing authoritarian North Korea in 2009, Kang Mi-Jin was regularly mobilized by the state for military-like productivity campaigns that were a source of both pride and pain. She was happy to be chosen to give a speech pledging loyalty to the ruling Kim family; less so when a tunneling const... Read the Full Story |
|
From Our PartnersWe've spent over 40 years building an A.I. that can rival even the best minds on Wall Street.
This advanced technology automatically recognizes patterns and improves its algorithm to pick the best trade.
Want to make your trading more comfortable AND more profitable as you navigate this ever-changing market? | | Attend our FREE live class now! |
|
Markets | | | A civil court trial began Friday in Japan over Nissan’s demand for 10 billion yen, or $95 million, in damages from its former chairman, Carlos Ghosn.
The automaker has sued Ghosn over what it says is harm suffered from various types of alleged financial misconduct. Ghosn jumped bail ... Read the Full Story |
|
Markets | | | Hillenbrand, Value Is Where You Find It
In light of the newly developed narrative of value versus growth, I find Hillenbrand (NYSE:HI) an attractive midcap. The company’s business is a bit unusual, it is a blend of industrial services and plastic molding services along with a healthy dos... Read the Full Story |
|
Markets | | | Vroom Is Another Case Of Excellent Isn’t Good Enough
Vroom (NASDAQ:VRM) emerged as a pandemic-winner over the summer for a couple of reasons including 1) strong eCommerce trends and 2) strong used-car trends. Those trends have produced some strong growth for the company but there is one thing... Read the Full Story |
|
Markets | | |
If any company has taken a beating this year, it's Disney (NYSE:DIS). The House of Mouse has been pasted as virtually every sector of its operations has been impacted negatively by the pandemic: its parks are barely operational even eight months after lockdowns kicked in for the first time, its ab... Read the Full Story |
|
Markets | | | O’Reilly Automotive (NASDAQ: ORLY) reported its Q3 2020 earnings two weeks ago, and the numbers were outstanding. Earnings were $7.07 per share, handily beating estimates of $6.22 and up 39% yoy. Same-store sales increased 16.9% yoy.
There were whispers that O’Reilly’s 27-year ste... Read the Full Story |
|
The Early Bird Stock Of The Day Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California. | | View Today's Stock Pick |
|
